Scheme

ICICI Prudential Nifty Pharma Index Fund

Holds 20 companies worth ₹163 Cr in Sept 2026.

Fund house
ICICIThe fund house that runs this scheme.
AUM
₹163 CrICICI Prudential Nifty Pharma Index Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Up 4.0% on Aug 2026, ₹157 Cr.
Largest holding
Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 19.5% of this scheme's NAV.
Fund manager
Venus AhujaRuns it since 1 Nov 2025, as the fund house dates it. With Nishit Patel (co-manager), Ashwini Bharucha (co-manager).

Holdings^{(Dec 2022 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	20 companies ·	₹ Cr
	Sun Pharmaceutical Ind Ltd	31.8
	Divi s Laboratories Limited	19.5
	Laurus Labs Limited	12.8
	Cipla	12.5
	Dr Reddy s Laboratories Limited	12.4
	Torrent Pharmaceuticals Limited	11.7
	Lupin	8.2
	Aurobindo Pharma	7.6
	Glenmark Pharmaceuticals	5.8
	Alkem Laboratories Limited	5.2
	Cadila Healthcare	4.8
	Mankind Pharma Limited	4.7
	IPCA Laboratories Limited	4.4
	Biocon	4.3
	Gland Pharma Limited	3.8
	Sai Life Sciences Limited	3.5
	Wockhardt	2.9
	Ajanta Pharmaceuticals Limited	2.7
	Abbott India Limited	2.3
	Piramal Pharma Limited	2.1

Sun Pharmaceutical Ind Ltd
Divi s Laboratories Limited

Market value of each ticked company in ICICI Prudential Nifty Pharma Index Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Sun Pharmaceutical Ind Ltd	Divi s Laboratories Limited
Sept 2025	₹19 Cr	₹8.2 Cr
Oct 2025	₹20.1 Cr	₹9.7 Cr
Nov 2025	₹21.8 Cr	₹9.3 Cr
Dec 2025	₹20.8 Cr	₹9.3 Cr
Jan 2026	₹19.6 Cr	₹8.9 Cr
Feb 2026	₹21.2 Cr	₹9.4 Cr
Mar 2026	₹24 Cr	₹9.7 Cr
Apr 2026	₹25.6 Cr	₹11 Cr
May 2026	₹27.8 Cr	₹12.4 Cr
Jun 2026	₹29 Cr	₹12.3 Cr
Jul 2026	₹31.6 Cr	₹15.3 Cr
Aug 2026	₹32.6 Cr	₹18.6 Cr
Sept 2026	₹31.8 Cr	₹19.5 Cr

Fig. 1.Market value of each ticked company in ICICI Prudential Nifty Pharma Index Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of NAV
Large Cap	4	46.31

Mid Cap	12	46.08

Small Cap	4	7.55

Cash & others		0.061

Sectors

Companies

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Buying and selling, month by month^{(Oct 2025 – Sept 2026)}

Buying and selling, month by month. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Portfolio^{(Sept 2026)}

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Sun Pharmaceutical Ind Ltd	Equity	Pharmaceuticals & Biotechnology	1.75L	31.8	19.50
Divi s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	21K	19.5	11.97
Laurus Labs Limited	Equity	Pharmaceuticals & Biotechnology	64.4K	12.8	7.82
Cipla	Equity	Pharmaceuticals & Biotechnology	93.1K	12.5	7.68
Dr Reddy s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	1.01L	12.4	7.62
Torrent Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	24.3K	11.7	7.16
Lupin	Equity	Pharmaceuticals & Biotechnology	40.2K	8.2	5.00
Aurobindo Pharma	Equity	Pharmaceuticals & Biotechnology	45.7K	7.6	4.68
Glenmark Pharmaceuticals	Equity	Pharmaceuticals & Biotechnology	24.9K	5.8	3.56
Alkem Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	9.97K	5.2	3.16
Cadila Healthcare	Equity	Pharmaceuticals & Biotechnology	41K	4.8	2.92
Mankind Pharma Limited	Equity	Pharmaceuticals & Biotechnology	18.7K	4.7	2.88
IPCA Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	23K	4.4	2.71
Biocon	Equity	Pharmaceuticals & Biotechnology	1.15L	4.3	2.62
Gland Pharma Limited	Equity	Pharmaceuticals & Biotechnology	13.2K	3.8	2.34
Sai Life Sciences Limited	Equity	Pharmaceuticals & Biotechnology	22.9K	3.5	2.14
Wockhardt	Equity	Pharmaceuticals & Biotechnology	13.7K	2.9	1.77
Ajanta Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	7.54K	2.7	1.67
Abbott India Limited	Equity	Pharmaceuticals & Biotechnology	861	2.3	1.43
Piramal Pharma Limited	Equity	Pharmaceuticals & Biotechnology	1.03L	2.1	1.30

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.